« Anthrim(TM), Anthrax Antibody Therapeutic, Passes Phase 1 Human Clinical Trial | Main | Prograf®, FDA Approved for Heart (transplant) Indication »

Mar30
Potential Market for Novel Allergy Medications

First, I wanna thank a long time friend and colleague, Ruth Schaffer (now a "colleague" in the science blogosphere) for guest blogging here at The PharmVoice.

I myself am dependent on Claritin to relieve me of my itchy symptoms and am fairly satisifed with the results. My son uses Fenistil drops and so far, it works. But according to the results of a survey released last week by The Asthma and Allergy Foundation of America (AAFA),

  • 31% are not satisfied with their current allergy prescription
  • 60% are interested in finding a new drug
  • 55% said that their current medication does not relieve their allergy symptoms for a long enough period of time
  • 44% said their medication doesn't provide quick enough relief

So many numbers. All it boils down to is the fact that a significant number of allergy sufferers are not satisfied with their medications, whether oral or nasal.

A lucrative market for pharmaceutical companies, I say, including manufacturers of generic allergy medications.



Ruth Schaffer writes at The Biotech Weblog, Allergizer and Let's Visit Asia.

related entries


3 Comments/Trackbacks




» Looking for Better Allergy Medications? from Allergies
Pardon the sporadic posting. I am currently on travel, and have been having sneezing attacks recently. Good thing there's Claritin. And my son's Fenistil is tucked safely in his bag. How about you? What anti-allergy medications do you rely on?... [Read More]

» Guest Bloggers Featured on the KMM Network, Thursday from Know More Media
We were privileged to hear from another solid group of new voices on Thursday. They were:  David Schappell: ‘How to Encourage Blogging by Customer-Facing Employees?’ on KnowMoreMedia. Ruth Schaffer: ‘Potential Market for Novel Al... [Read More]

Good info here for those us us upright because of allergy meds. Thanks Mine is Alegra, but it would be nice to get a cure for these pesky allergies, and stop the meds, so we can stop paying the medical blokes in drug dollars. How far away are we?

submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« Anthrim(TM), Anthrax Antibody Therapeutic, Passes Phase 1 Human Clinical Trial | Main | Prograf®, FDA Approved for Heart (transplant) Indication »

Advertise

Watch the Digital Health Revolution


sponsored ads



Incredible Hall of Acclaim.

subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

WebMetricsGuru

TheInsurancePolicy

MarketingBlurb